Bandak Ghassan, Kashani Kianoush B
Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Research Group, Mayo Clinic, Rochester, MN, USA.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
F1000Res. 2017 Nov 1;6:1930. doi: 10.12688/f1000research.11401.1. eCollection 2017.
Over the past few years, chloride has joined the league of essential electrolytes for critically ill patients. Dyschloremia can occur secondary to various etiologic factors before and during patient admission in the intensive care unit. Some cases are disease-related; others, treatment-related. Chloride abnormalities were shown in animal models to have adverse effects on arterial blood pressure, renal blood flow, and inflammatory markers, which have led to several clinical investigations. Hyperchloremia was studied in several settings and correlated to different outcomes, including death and acute kidney injury. Baseline hypochloremia, to a much lesser extent, has been studied and associated with similar outcomes. The chloride content of resuscitation fluids was also a subject of clinical research. In this review, we describe the effect of dyschloremia on outcomes in critically ill patients. We review the major studies assessing the chloride content of resuscitation fluids in the critically ill patient.
在过去几年中,氯离子已加入重症患者必需电解质的行列。在重症监护病房患者入院前及入院期间,各种病因均可导致氯代谢紊乱。有些病例与疾病相关;另一些则与治疗相关。动物模型显示,氯离子异常对动脉血压、肾血流量和炎症标志物有不良影响,这引发了多项临床研究。在多种情况下对高氯血症进行了研究,并将其与包括死亡和急性肾损伤在内的不同结局相关联。在较小程度上,也对基线低氯血症进行了研究,并发现其与类似结局相关。复苏液中的氯离子含量也是临床研究的一个课题。在本综述中,我们描述了氯代谢紊乱对重症患者结局的影响。我们回顾了评估重症患者复苏液氯离子含量的主要研究。